Autoimmune Diseases  >>  MP-435  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MP-435 / Mitsubishi Tanabe
NCT01143337: Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Completed
2
112
Japan
MP-435(dose1) + Methotrexate, Placebo + Methotrexate
Mitsubishi Tanabe Pharma Corporation
Rheumatoid Arthritis
03/12
03/12

Download Options